132 related articles for article (PubMed ID: 37466582)
1. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
[TBL] [Abstract][Full Text] [Related]
3. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
[TBL] [Abstract][Full Text] [Related]
5. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
Zeitlinger L; Wilson M; Randall RL; Thorpe S;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
[TBL] [Abstract][Full Text] [Related]
6. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
[TBL] [Abstract][Full Text] [Related]
8. What is the Cumulative Incidence of Revision Surgery and What Are the Complications Associated With Stemmed Cementless Nonextendable Endoprostheses in Patients 18 Years or Younger With Primary Bone Sarcomas About the Knee.
El Ghoneimy AM; Shehab AM; Farid N
Clin Orthop Relat Res; 2022 Jul; 480(7):1329-1338. PubMed ID: 35171125
[TBL] [Abstract][Full Text] [Related]
9. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
[TBL] [Abstract][Full Text] [Related]
10. Central Adjudication Committee and Clinical Site Investigator Agreement on Outcomes in the PARITY Trial: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Giglio V; Gazendam AM; Schneider P; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):73-78. PubMed ID: 37466583
[TBL] [Abstract][Full Text] [Related]
11. Does the Addition of a Vascularized Fibula Improve the Results of a Massive Bone Allograft Alone for Intercalary Femur Reconstruction of Malignant Bone Tumors in Children?
Errani C; Alfaro PA; Ponz V; Colangeli M; Donati DM; Manfrini M
Clin Orthop Relat Res; 2021 Jun; 479(6):1296-1308. PubMed ID: 33497066
[TBL] [Abstract][Full Text] [Related]
12. Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.
Thornley P; Vicente M; MacDonald A; Evaniew N; Ghert M; Velez R
Clin Orthop Relat Res; 2019 Apr; 477(4):894-902. PubMed ID: 30801278
[TBL] [Abstract][Full Text] [Related]
13. Is the Addition of Anaerobic Coverage to Perioperative Antibiotic Prophylaxis During Soft Tissue Sarcoma Resection Associated With a Reduction in the Proportion of Wound Complications?
Ramsey DC; Walker JR; Wetzel R; Gundle KR; Hayden JB; Doung YC
Clin Orthop Relat Res; 2022 Dec; 480(12):2409-2417. PubMed ID: 35901448
[TBL] [Abstract][Full Text] [Related]
14. What Is the Survival of the Telescope Allograft Technique to Augment a Short Proximal Femur Segment in Children After Resection and Distal Femur Endoprosthesis Reconstruction for a Bone Sarcoma?
Hindiskere S; Staals E; Donati DM; Manfrini M
Clin Orthop Relat Res; 2021 Aug; 479(8):1780-1790. PubMed ID: 33635286
[TBL] [Abstract][Full Text] [Related]
15. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?
Gazendam AM; Schneider P; Spiguel A; Ghert M
Ann Surg Oncol; 2022 Nov; 29(12):7312-7317. PubMed ID: 35864365
[TBL] [Abstract][Full Text] [Related]
17. Proximal Tibia Reconstruction After Bone Tumor Resection: Are Survivorship and Outcomes of Endoprosthetic Replacement and Osteoarticular Allograft Similar?
Albergo JI; Gaston CL; Aponte-Tinao LA; Ayerza MA; Muscolo DL; Farfalli GL; Jeys LM; Carter SR; Tillman RM; Abudu AT; Grimer RJ
Clin Orthop Relat Res; 2017 Mar; 475(3):676-682. PubMed ID: 27103142
[TBL] [Abstract][Full Text] [Related]
18. Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?
Aponte-Tinao LA; Ayerza MA; Albergo JI; Farfalli GL
Clin Orthop Relat Res; 2020 Mar; 478(3):517-524. PubMed ID: 32168064
[TBL] [Abstract][Full Text] [Related]
19. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
20. Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors.
Tran TH; Hayden JB; Gazendam AM; Ghert M; Gundle KR; Doung YC;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):22-28. PubMed ID: 37466576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
